Paliperidone (Invega) is a metabolite of risperidone (Risperidone). While the efficacy and side effects of these medications are similar, there are some difference in 5-HT2A/D2 (serotonin/dopamine) binding ratios. The risperidone binding ratio is lower than the paliperidone binding ratio. More information is available here.
If you would like more information on this topic, or would like to provide any feedback, please send us a message using our
consultation system. Be sure to let us know about which tip you are writing. We would love to hear from you, and the consultation system is free to use and confidential. Thank you!
Type: Resources (Clinicians)
Answered by:
Alexander S. Young, MD, MSHS, SMI Physician Expert - University of California, Los Angeles
Date Answered: February 10, 2020
Topic:
Psychopharmacology Interventions
Subtopics:
Biomarkers and Genetics ,
Older Medications
